Recombinant DNA Advisory Committee

177 - The development of cancer immunotherapy and its promise for treating advanced cancers

Peter Attia MD

A government committee that reviewed and ultimately approved Dr. Rosenberg's proposal to introduce a marker gene into human lymphocytes, a landmark decision for human gene therapy.